BCAX   $19.125  0.03% Market Closed After Close 19.12 -0.03%

Bicara Therapeutics Inc
Total Cash 203.86M
totalCashPerShare 199.162
EBITDA -58.30M
Total Debt 517.00K
quickRatio 12.689
currentRatio 12.827
Total Revenue
debtToEquity 0.269
Revenue/Share
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -46.06M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 188.51M
forwardPE -14.913043
floatShares 592.98K
sharesOutstanding 54.39M
sharesShort 659.04K
sharesShortPriorMonth 0.00
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.07%
heldPercentInstitutions 0.33%
Short Ratio help_outline 3.09%
shortPercentOfFloat
impliedSharesOutstanding
bookValue -170.752
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -64.84M
trailingEps -3.75%
forwardEps -1.61%
enterpriseToEbitda -3.23
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.46
institutionsCount 10
lastUpdated Nov. 2, 2024, 8:07 a.m.